Biogen Inc

NASDAQ:BIIBUnited States

Yesterday

Show headlines and story abstract

• Biogen Receives Positive CHMP Opinion for TOFIDENCE(TM) (tocilizumab), a Biosimilar Referencing ROACTEMRA(R), from 19 hours ago by Dow Jones

  19 hours ago by Dow Jones
  Companies Mentioned: BIIB
  -- CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing TOFIDENCE(TM) to the reference product ROACTEMRA(R)
  CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Biogen https://www.globenewswire.com/Tracker?data=JltSjy9lWtnRNP_h46Do6CQXMKhX9f9BXMsNLgqhTdWgQfB8rptF2yBxnQhitNgFarf6yZ-9wh0a7LjOM-p-vQ== Inc. (Nasdaq: BIIB) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for TOFIDENCE(TM) (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA(R)1 . The intravenous formulation of TOFIDENCE has been recommended for approval for the treatment of moderate to severely active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, systemic juvenile idiopathic arthritis and COVID-19.
  

• DJ Biogen Is Maintained at Equal-Weight by Barclays, from 20 hours ago by Dow Jones

  20 hours ago by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 25, 2024 14:12 ET (18:12 GMT)
  

• DJ Biogen Is Maintained at Neutral by Wedbush, from 8:42AM ET on Thursday Apr 25, 2024 by Dow Jones

  8:42AM ET on Thursday Apr 25, 2024 by Dow Jones
  Companies Mentioned: BIIB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/BIIB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 25, 2024 08:42 ET (12:42 GMT)
  

• --Goldman Sachs Adjusts Biogen Price Target to $340 From $393, from 8:18AM ET on Thursday Apr 25, 2024 by MT Newswires

  8:18AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
  08:18 AM EDT, 04/25/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...

• --Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305, from 8:03AM ET on Thursday Apr 25, 2024 by MT Newswires

  8:03AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
  08:03 AM EDT, 04/25/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...